Enzyme News and Research

RSS

Researchers identify molecular processes in kidney cells that attract and feed COVID-19

Although the lungs are a common target for COVID-19's cytokine storm, so are the kidneys, making the 1 in 4 U.S. adults with diabetes resulting in diabetic kidney disease at increased risk for virus mortality.

23 Oct 2020

Molecular processes in kidney cells may increase diabetics' vulnerability to COVID-19 infection

People with diabetes -- especially the 20 to 40 percent with diabetic kidney disease -- are among the most at risk for serious complications and death from COVID-19.

23 Oct 2020

ACROBiosystems and the Fight Against COVID-19

In this interview, Dr. Yinang Jiang discusses ACROBiosystems and their efforts in the fight against COVID-19 and the search for a vaccine

From ACROBiosystems 23 Oct 2020

New technique could propel personalized cancer treatments

When it comes to defeating cancer, some immune cells are mightier than others. But even the best-trained eye and today's advanced scientific tools have trouble discerning the most powerful tumor-fighting cells from the rest.

23 Oct 2020

New method can detect high levels of COVID-19 antibodies

A more efficient and much faster method to assess high levels of neutralizing antibodies to COVID-19 could point the way to better understanding and treatment of the disease, according to new published findings by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and the University of Michigan (U-M).

23 Oct 2020

Seropositivity to SARS-CoV-2 among asymptomatic blood donors in New York

New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.

23 Oct 2020

DNA vaccine-induced antibodies neutralize SARS-CoV-2

The coronavirus disease (COVID-19) is far from over as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage across the globe. With the vast spread of the virus, many countries who reported flattening the curve over the past months have reported clusters of new cases and second waves of the outbreak.

22 Oct 2020

New method for producing FTVI enzyme can help improve cord blood transplants

A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.

22 Oct 2020

Researchers use molecular dynamics simulations to identify secrets of SARS-CoV-2 virus

The virus wreaking havoc on our lives is an efficient infection machine. Comprised of only 29 proteins (compared to our 400,000), with a genome 1/200,000 the size of ours, SARS-CoV-2 is expertly evolved to trick our cells to contribute its machinery to assist in its propagation.

22 Oct 2020

Ancient elements in human DNA can activate powerful immune response to kill cancer cells

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

22 Oct 2020

Study sheds light on working principles of various advanced biosensing technologies

The COVID-19 pandemic is undoubtedly the most challenging global health burden since the 2nd World War. The pandemic has raised social awareness on the importance of effective and timely diagnosis that may help minimize the risk of contracting and spreading COVID-19.

22 Oct 2020

Researchers identify new mechanism that modulates cell division

Collaborative work of research groups at the University of Würzburg and the TU Dresden has provided important new insights for cancer research.

22 Oct 2020

SARS-CoV-2 mutations dictate severity of COVID-19 disease

A recent study by researchers from Semmelweis University and Pazmany Peter Catholic University in Budapest, Hungary, published on the preprint server medRxiv in October 2020, shows the relationship of specific mutations on the disease's outcome.

22 Oct 2020

Brain metabolic changes associated with loss of smell in COVID-19

A recent study detailed in a preprint paper published in medRxiv, researchers from Belgium, discuss how they investigated possible central nervous system (CNS) involvement in COVID-19 patients with a sudden loss of smell using a hybrid positron emission tomography (PET)-magnetic resonance imaging (MRI) system (PET-MR).

21 Oct 2020

Study characterizes biochemical mechanism of cancer-linked enzyme

A new study led by scientists at IUPUI and Indiana University Bloomington is the first to describe a biochemical mechanism that increases the activity of a molecule whose presence is observed in many types of cancer.

21 Oct 2020

UCLA researchers discover compound that stimulates muscle cells in mice

UCLA researchers have identified a compound that can reproduce the effect of exercise in muscle cells in mice. The findings are published in the journal Cell Reports Medicine.

21 Oct 2020

New DNA-cutting tool could advance gene editing for novel treatments

Gene editing for the development of new treatments, and for studying disease as well as normal function in humans and other organisms, may advance more quickly with a new tool for cutting larger pieces of DNA out of a cell's genome, according to a new study by UC San Francisco scientists.

21 Oct 2020

Scientists uncover a novel cellular mechanism for disposing of misfolded proteins

About 30 years ago, Dr. Richard Sifers set out on a journey to discover why people with a rare condition known as alpha1-antitrypsin deficiency present with high variation in the severity of liver disease.

21 Oct 2020

Researchers explore SARS-CoV-2 at single cell resolution in human airway epithelial cells

The cellular tropism of the SARS-CoV-2 virus affects several aspects of infection, such as the spread of the virus within and between hosts, tissue pathology, immune control mechanisms, and the response to treatment with promising antiviral drugs.

21 Oct 2020

Researchers explore effect of temperature on molecular structure of SARS-CoV-2 spike

Didac Martí et al., from the Polytechnic University of Catalonia, in a recent bioRxiv preprint research paper, explore the effect of the temperature on the molecular structure of the SARS-CoV-2 spike glycoprotein. The study specifically focuses on the spike glycoprotein's molecular structural integrity at different temperatures (within 25 ºC and 100 ºC) using atomistic computer simulations.

20 Oct 2020

Enzyme News and Research

Researchers identify molecular processes in kidney cells that attract and feed COVID-19

Molecular processes in kidney cells may increase diabetics' vulnerability to COVID-19 infection

ACROBiosystems and the Fight Against COVID-19

New technique could propel personalized cancer treatments

New method can detect high levels of COVID-19 antibodies

Seropositivity to SARS-CoV-2 among asymptomatic blood donors in New York

DNA vaccine-induced antibodies neutralize SARS-CoV-2

New method for producing FTVI enzyme can help improve cord blood transplants

Researchers use molecular dynamics simulations to identify secrets of SARS-CoV-2 virus

Ancient elements in human DNA can activate powerful immune response to kill cancer cells

Study sheds light on working principles of various advanced biosensing technologies

Researchers identify new mechanism that modulates cell division

SARS-CoV-2 mutations dictate severity of COVID-19 disease

Brain metabolic changes associated with loss of smell in COVID-19

Study characterizes biochemical mechanism of cancer-linked enzyme

UCLA researchers discover compound that stimulates muscle cells in mice

New DNA-cutting tool could advance gene editing for novel treatments

Scientists uncover a novel cellular mechanism for disposing of misfolded proteins

Researchers explore SARS-CoV-2 at single cell resolution in human airway epithelial cells

Researchers explore effect of temperature on molecular structure of SARS-CoV-2 spike

Biochemical Assays for Efficient Hit Prioritization After Screening eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo